THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets
2019 · British Journal of Pharmacology · 425 citations
https://doi.org/10.1111/bph.14747
D
Doriano Fabbro
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
350
Papers
29.6K
Citations
89
h-index
197
i10-index
Doriano Fabbro is an academic researcher from DecImmune Therapeutics (United States). The author has contributed to research in topics: PI3K/AKT/mTOR signaling in cancer & Chronic Myeloid Leukemia Treatments & Chronic Lymphocytic Leukemia Research. The author has an h-index of 89, co-authored 298 publications.
ORCID: 0000-0002-9400-4517Papers by this author
worksAEE788
2004 · Cancer Research · 317 citations
https://doi.org/10.1158/0008-5472.can-03-3681
Specific CLK Inhibitors from a Novel Chemotype for Regulation of Alternative Splicing
2011 · Chemistry & Biology · 194 citations
https://doi.org/10.1016/j.chembiol.2010.11.009
Insulin-stimulated Protein Kinase B Phosphorylation on Ser-473 Is Independent of Its Activity and Occurs through a Staurosporine-insensitive Kinase
2001 · Journal of Biological Chemistry · 140 citations
https://doi.org/10.1074/jbc.c100174200
Nitric Oxide Induces Degradation of the Neutral Ceramidase in Rat Renal Mesangial Cells and Is Counterregulated by Protein Kinase C
2002 · Journal of Biological Chemistry · 60 citations
https://doi.org/10.1074/jbc.m204034200
Protein kinase C in human renal cell carcinomas: role in invasion and differential isoenzyme expression
2000 · British Journal of Cancer · 57 citations
https://doi.org/10.1054/bjoc.1999.1043
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat